Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cytoplasmic membrane is a vital phospholipid bilayer that serves as a selective permeability barrier and a scaffold for essential processes such as energy generation and cell wall synthesis. Unlike mammalian membranes, which are rich in neutral lipids, bacterial membranes contain high proportions of anionic lipids such as phosphatidylglycerol and cardiolipin, as well as associated components like lipoteichoic acids in Gram-positive species [3]. These anionic components create a negative surface charge that serves as a primary docking site for cationic antimicrobial agents [2]. Drugs like daptomycin exploit this charge difference to selectively bind, insert into the membrane, and cause physical disruption or depolarization [1]. This disruption leads to the loss of the proton motive force and leakage of vital ions like potassium, resulting in rapid bactericidal activity [4]. Because the membrane is essential for viability and its structural integrity is physically compromised, it remains a robust target for treating multi-drug resistant infections.
Antimicrobial agents target this structure by binding to anionic phospholipids (e.g., phosphatidylglycerol) or associated components (e.g., lipoteichoic acid), leading to membrane insertion, depolarization, pore formation, and leakage of intracellular ions like potassium, which halts cellular processes and induces cell death [1, 3].
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cytoplasmic membrane and associated anionic surface components.